Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)

Author：

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.45, Iss.5, 2014-01, pp. : 1793-1801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Effect of Lycopene on the PI3K/Akt Signalling Pathway in Prostate Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 6, 2014-01 ,pp. : 800-805

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/AKT pathway regulates E‐cadherin and Desmoglein 2 in aggressive prostate cancer

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1258-1271

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3169-3176

Spandidos Publications

Access to resources Recommend Favorite

Shikonin promotes autophagy in BXPC3 human pancreatic cancer cells through the PI3K/Akt signaling pathway

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1087-1089

Spandidos Publications

Access to resources Recommend Favorite

CD38 is highly expressed and affects the PI3K/Akt signaling pathway in cervical cancer

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2703-2709

Spandidos Publications

Access to resources Recommend Favorite